B 746

Known as: B-746, B746 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1987-1998
0119871998

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
1999
Review
1999
Riminophenazines were specifically developed as drugs active against Mycobacterium tuberculosis but extensive research over… (More)
  • figure 1
  • table I
  • figure 2
Is this relevant?
Review
1998
Review
1998
The development of new drugs with strong antituberculous activity and fewer side effects which are not cross-resistant to… (More)
Is this relevant?
1995
1995
Clofazimine (CFM), a riminophenazine drug, is primarily used in therapy for leprosy and Mycobacterium avium infections. With an… (More)
Is this relevant?
1993
1993
In the present study the individual and interactive effects of clofazimine, or three analogues of this agent (selected on the… (More)
Is this relevant?
1993
1993
Twenty-five compounds structurally related to clofazimine were tested for their ability to inhibit the growth of Mycobacterium… (More)
Is this relevant?
1992
1992
B746, an analogue of clofazimine, was compared with the parent compound for its activity against Mycobacterium avium complex (MAC… (More)
Is this relevant?
1988
1988
Clofazimine (Lamprene, B663) and 11 rimino-compounds were tested for activity against Mycobacterium avium by finding the minimal… (More)
Is this relevant?
1987
1987
The aim of this study was to search for new drugs active against the Mycobacterium avium complex and to re-examine the activity… (More)
Is this relevant?